Myriad Genetics, Inc. Contracts & Agreements

Lease Termination Agreement, dated December 18, 2023, between the Registrant and HCPI/Utah II, LLC (Filed With SEC on February 28, 2024)

Lease Termination Agreement, dated December 18, 2023, between Myriad Genetics, Inc. and HCPI/Utah II, LLC (Filed With SEC on February 28, 2024)

Lease Agreement, dated February 9, 2022, between Myriad Genetics, Inc. and Bay Bridge/Corporate, LLC (Filed With SEC on February 28, 2024)

Lease, effective December 7, 2021, between Myriad Women's Health, Inc. and Bayside Area Development, LLC (Filed With SEC on February 28, 2024)

Severance and Change of Control Agreement, dated December 11, 2023, by and between Myriad Genetics, Inc. and Samraat S. Raha (Filed With SEC on February 28, 2024)

Executive Employment Agreement, dated December 15, 2023, between Myriad Genetics, Inc. and Scott Leffler (Filed With SEC on February 28, 2024)

Separation and Consulting Agreement and Release of Claims, dated December 15, 2023, between Myriad Genetics, Inc. and R. Bryan Riggsbee (Filed With SEC on February 28, 2024)

Separation and Consulting Agreement and Release of Claims, dated October 4, 2023, by and between Myriad Genetics, Inc. and Nicole Lambert (Filed With SEC on February 28, 2024)

Underwriting Agreement, dated November 8, 2023, by and among the Company and Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC (Filed With SEC on November 13, 2023)

Employment Agreement, dated October 17, 2023, by and between Myriad Genetics, Inc. and Samraat S Raha (Filed With SEC on November 7, 2023)

First Amendment to Credit Agreement and Pledge and Security Agreement, dated as of October 31, 2023, among Myriad Genetics, Inc., the other loan parties party thereto, the lenders... (Filed With SEC on October 31, 2023)

Separation and Consulting Agreement and Release of Claims, dated October 4, 2023, by and between Myriad Genetics, Inc. and Nicole Lambert (Filed With SEC on October 5, 2023)

Non-Employee Director Compensation Policy (Filed With SEC on August 4, 2023)

Form of Restricted Stock Unit Agreement under the 2017 Equity Incentive Plan (Employee) (Filed With SEC on May 4, 2023)

Non-Employee Director Compensation Policy (Filed With SEC on November 2, 2022)

Amended and Restated 2012 Employee Stock Purchase Plan (Filed With SEC on June 2, 2022)

Separation and (Filed With SEC on February 9, 2022)

Amended and Restated 2012 Employee Stock Purchase Plan (Filed With SEC on November 4, 2021)

Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity (Filed With SEC on December 7, 2020)

Executive Employment Agreement between the Registrant and Paul J. Diaz dated July 24, 2020 (Filed With SEC on November 9, 2020)

Performance-Based Restricted Stock Unit Agreement between the Registrant and Paul J. Diaz dated October 8, 2020 (Filed With SEC on November 9, 2020)

Restricted Stock Unit Agreement between the (Filed With SEC on November 9, 2020)

Performance-Based Non-Qualified Stock Option Agreement between the Registrant and Paul J. Diaz dated August 13, 2020 (Filed With SEC on November 9, 2020)

Non-Qualified Stock Option Agreement between the Registrant and Paul J. Diaz dated August 13, 2020 (Filed With SEC on November 9, 2020)

Form of Separation and Release (Filed With SEC on November 9, 2020)

Form of Severance and Change in Control Agreement (Filed With SEC on October 15, 2020)

2017 Employee, Director and Consultant Equity Incentive Plan, as amended as of October 9, 2020 (Filed With SEC on October 15, 2020)

Form of Restricted Stock Unit Agreement (Filed With SEC on August 13, 2020)

Separation and Consulting Agreement, dated May 6, 2020, by and between Myriad Genetics, Inc. and Mark C. Capone (Filed With SEC on May 12, 2020)

Form of Executive Retention Agreement (Filed With SEC on February 7, 2020)

Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (Filed With SEC on December 6, 2019)

Lease Agreement, dated January 31, 2019 between the Registrant and Boyer Research Park Associates X, L.C., by its Manager, The Boyer Company, L.C (Filed With SEC on August 13, 2019)

Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (Filed With SEC on November 30, 2018)

Form of Executive Retention Agreement, as amended (Filed With SEC on November 7, 2018)

Form of Indemnification Agreement (Filed With SEC on November 7, 2018)

Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on December 1, 2017)

Myriad Genetics, Inc. 2013 Executive Incentive Plan, As Amended (Filed With SEC on December 1, 2017)

List of executed Executive Retention Agreements between Myriad Genetics Inc. and listed executives (Filed With SEC on November 8, 2017)

List of executed Indemnification Agreements between Myriad Genetics Inc. and listed executives (Filed With SEC on November 8, 2017)

CREDIT AGREEMENT dated as of December 23,2016 among MYRIAD GENETICS,INC. The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A. as Administrative Agent and Collateral Agent WELLS... (Filed With SEC on February 8, 2017)

MYRIAD GENETICS, INC. 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMENDED (as amended on December 1, 2016) (Filed With SEC on December 2, 2016)

AGREEMENT AND PLAN OF MERGER among: MYRIAD GENETICS, INC. a Delaware corporation; MYRIAD MERGER SUB, INC., a Delaware corporation; ASSUREX HEALTH, INC., a Delaware corporation;... (Filed With SEC on November 2, 2016)

CREDIT AGREEMENT dated as of August 31, 2016 among MYRIAD GENETICS, INC. The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A. as Administrative Agent JPMORGAN CHASEBANK, N.A.,... (Filed With SEC on November 2, 2016)

INDEMNIFICATION AGREEMENT (Filed With SEC on November 2, 2016)

MYRIAD GENETICS, INC. Executive Retention Agreement (Filed With SEC on November 2, 2016)

MYRIAD GENETICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Effective: Fiscal Year 2017) (Filed With SEC on August 10, 2016)

SIXTH AMENDMENT TO LEASE (Myriad Genetics: Phase I) (Filed With SEC on May 4, 2016)

FIFTH AMENDMENT TO LEASE (Myriad Genetics: Phase II) (Filed With SEC on May 4, 2016)

SECOND AMENDMENT TO LEASE (Myriad Genetics: Phase III) (Filed With SEC on May 4, 2016)

SECOND AMENDMENT TO LEASE AGREEMENT (Myriad Genetics: Phase IV) (Filed With SEC on May 4, 2016)

MYRIAD GENETICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Effective December 2, 2015) (Filed With SEC on February 3, 2016)

MYRIAD GENETICS, INC. 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMENDED (as amended on December 3, 2015) (Filed With SEC on December 7, 2015)

MYRIAD GENETICS, INC. Executive Retention Agreement (Filed With SEC on November 4, 2015)

MYRIAD GENETICS, INC. Amendment to Executive Retention Agreement (Filed With SEC on October 2, 2015)

MYRIAD GENETICS, INC. Executive Retention Agreement (Filed With SEC on February 4, 2015)

RESIGNATION AGREEMENT (Filed With SEC on February 3, 2015)

MYRIAD GENETICS, INC. Restricted Stock Unit Award Grant Notice Restricted Stock Unit Award Grant under the Companys 2010 Employee, Director and Consultant Equity Incentive Plan,... (Filed With SEC on November 5, 2014)

MYRIAD GENETICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Effective Fiscal Year 2015) (Filed With SEC on November 5, 2014)

MYRIADGENETICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on October 9, 2014)

RESIGNATION AGREEMENT (Filed With SEC on October 9, 2014)

AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER BY AND AMONG MYRIADGENETICS, INC., MYRIAD CRESCENDO, INC., CRESCENDO BIOSCIENCE, INC. AND MDV IX, L.P., AS REPRESENTATIVE Dated... (Filed With SEC on February 4, 2014)

MYRIAD GENETICS, INC. 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITYINCENTIVE PLAN, AS AMENDED (as approved by stockholders on December 5, 2013) (Filed With SEC on December 6, 2013)

MYRIAD GENETICS, INC. 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITYINCENTIVE PLAN, AS AMENDED (as amended on December 5, 2012) (Filed With SEC on December 7, 2012)

MYRIAD GENETICS, INC. 2012 EMPLOYEE STOCK PURCHASE PLAN (as approved by stockholders on December 5, 2012) (Filed With SEC on December 7, 2012)

MYRIAD GENETICS, INC. 2013 EXECUTIVE INCENTIVE PLAN Adopted effective: September 12, 2012 Approved by the Stockholders: December 5, 2012 (Filed With SEC on December 7, 2012)

MYRIAD GENETICS, INC. 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITYINCENTIVE PLAN, AS AMENDED (as last amended December 2, 2011) (Filed With SEC on December 5, 2011)

MYRIAD GENETICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Effective Fiscal Year 2012) (Filed With SEC on November 2, 2011)

Exhibit 4.1 1 MYRIAD GENETICS, INC. (Filed With SEC on August 15, 2011)

Exhibit 10.22 (Filed With SEC on August 15, 2011)

Exhibit 10.25 MYRIAD GENETICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Effective Fiscal Year 2012) (Filed With SEC on August 15, 2011)

ARTICLE 1 DEFINITIONS (Filed With SEC on May 4, 2011)

AGREEMENT AND PLAN OF MERGER by and between RULES-BASED MEDICINE, INC., MYRIAD GENETICS, INC., MYRIAD RBM, INC. and MARK CHANDLER, Ph.D., AS REPRESENTATIVE APRIL 27, 2011 TABLE OF... (Filed With SEC on May 3, 2011)

MYRIAD GENETICS, INC. EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED (as approved by shareholders on November 16, 2006, and as amended by the Board of Directors on December 22, 2010,... (Filed With SEC on February 1, 2011)

MYRIAD GENETICS, INC. Stock Option Grant Notice Stock Option Grant under the Companys 2010 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on February 1, 2011)

MYRIAD GENETICS, INC. Director Stock Option Grant Notice Non-Qualified Stock Option Grant under the Companys 2010 Employee, Director and Consultant Equity Incentive Plan pursuant... (Filed With SEC on February 1, 2011)

MYRIAD GENETICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Effective September 16, 2010) (Filed With SEC on November 3, 2010)

AMENDMENT NO. 1 TO SUBLEASE AGREEMENT RESEARCH PARK BUILDING - PHASE V (Filed With SEC on August 12, 2010)

AMENDMENT NO. 2 TO SUBLEASE AGREEMENT RESEARCH PARK BUILDING - PHASE V (Filed With SEC on August 12, 2010)

Exhibit 10.1 MYRIAD GENETICS, INC. Form of Executive Retention Agreement (Filed With SEC on May 5, 2010)

Exhibit 10.2 MYRIAD GENETICS, INC. Amendment to Executive Retention Agreement (Filed With SEC on May 5, 2010)

Exhibit 10.4 AMENDMENT TO LEASE AGREEMENT (Myriad Genetics: Phase v) (Filed With SEC on May 5, 2010)

MYRIAD GENETICS, INC. 2003 EMPLOYEE, DIRECTOR ANDCONSULTANT STOCK OPTION PLAN, AS AMENDED (Filed With SEC on February 3, 2010)

RESIGNATION AGREEMENT (Filed With SEC on February 2, 2010)

MYRIAD GENETICS, INC. 2003 EMPLOYEE, DIRECTOR ANDCONSULTANT STOCK OPTION PLAN, AS AMENDED (Filed With SEC on November 6, 2009)

MYRIAD GENETICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on August 26, 2009)

Form of Director and Executive Officer INDEMNIFICATION AGREEMENT (Filed With SEC on August 26, 2009)

COMPENSATION OF NAMED EXECUTIVE OFFICERS (Filed With SEC on August 26, 2009)

SEPARATION AND DISTRIBUTION AGREEMENT by and between (Filed With SEC on July 7, 2009)

TAX SHARING AGREEMENT (Filed With SEC on July 7, 2009)

SUBLEASEAGREEMENT (Filed With SEC on July 7, 2009)

EMPLOYEE MATTERS AGREEMENT by and between MYRIAD GENETICS, INC. and (Filed With SEC on July 7, 2009)

Exhibit 10.1 MYRIAD GENETICS, INC. 2003 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK OPTION PLAN, (Filed With SEC on November 19, 2008)

MYRIAD GENETICS, INC. Amendment to Executive Retention Agreement (Filed With SEC on February 5, 2008)

MYRIAD GENETICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on November 6, 2007)

RESIGNATION AGREEMENT (Filed With SEC on November 6, 2007)

1. DEFINITIONS (Filed With SEC on November 1, 2007)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 1, 2007)

EXCLUSIVE LICENSE AGREEMENT BETWEEN MYRIAD GENETICS, INC. AND (Filed With SEC on November 1, 2007)

LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 1, 2007)

Myriad Genetics, Inc. Management Performance Program (Filed With SEC on November 1, 2007)

Myriad Genetics, Inc. Non-Employee Director Compensation Policy (Filed With SEC on November 1, 2007)

MYRIAD GENETICS, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on November 1, 2007)

MYRIAD GENETICS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on November 1, 2007)

MYRIAD GENETICS, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on November 1, 2007)

MYRIAD GENETICS, INC. NON-QUALIFIED OPTION AGREEMENT (Filed With SEC on November 1, 2007)

COMPENSATION OF NAMED EXECUTIVE OFFICERS (Filed With SEC on August 29, 2007)

Myriad Genetics, Inc. 3,000,000 Shares of Common Stock (Filed With SEC on February 9, 2007)

MYRIAD GENETICS, INC. Executive Retention Agreement (Filed With SEC on February 6, 2007)

EXHIBIT 10.1 COMPENSATION OF NAMED EXECUTIVE OFFICERS (Filed With SEC on June 21, 2006)

Myriad Genetics, Inc. (Filed With SEC on November 4, 2005)

3,400,000 Shares (Filed With SEC on June 4, 2004)

Exhibit 10.1 MYRIAD GENETICS, INC. (Filed With SEC on February 10, 2004)

Category

Industry

Companies

Contracts

Myriad Genetics, Inc. Contracts & Agreements